Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA
Numerous studies have shown evidence supporting the benefits of universal newborn screening for primary immunodeficiencies (PID) and for Spinal Muscular Measuring Jug Atrophy (SMA).We have developed a four-plex, real-time PCR assay to screen for Severe Combined Immune Deficiencies (SCID), X-linked agammaglobulinemia (XLA), and SMA in DNA extracted